Chris Moxham

Chris Moxham is the Co-Founder, CEO, and CSO of Transcripta Bio, a pioneering biotech company charting a faster path in drug discovery to create better lives for people around the world. A a seasoned veteran with over 25 years of drug discovery experience, he earned his PhD in Molecular and Cellular Pharmacology at Stony Brook University before beginning his long career in drug development.

Before founding Transcripta Bio, Chris spent two decades at Eli Lilly, where he was instrumental in advancing over 10 molecules into clinical trials across multiple therapeutic areas and both small and large molecule modalities. His commitment to scientific advancement and team growth illustrates the impact he has had on Biotech and Pharmaceuticals industry.